Drug Profile
Linvencorvir - Roche
Alternative Names: CpAM - Roche; RG-7907; RO-7049389Latest Information Update: 28 Dec 2023
Price :
$50
*
At a glance
- Originator Roche
- Class Antivirals; Small molecules
- Mechanism of Action Viral core protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 10 Nov 2023 Efficacy data from a phase II trial in Hepatitis B presented at the 74th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD-2023)
- 10 Nov 2023 Pharmacodynamics data from a preclinical trial in Hepatitis B presented at the 74th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD-2023)
- 04 Nov 2022 Pharmacodynamics data from a preclinical trial in Hepatitis B presented at the 73rd Annual Meeting of the American Association for the Study of Liver Diseases Session (AASLD-2022)